MMA Spectrum Foundation Presents BioSpectrum Lifetime Achievement Award 2025 to Dilip Shanghvi

MMA Spectrum Foundation and BioSpectrum India, an integrated B2B media platform for the healthcare and bioscience industry in India, proudly presented Dilip Shanghvi, Founder and Executive Chairman, Sun Pharmaceutical Industries with BioSpectrum Lifetime Achievement Award 2025 at a glittering function held in New Delhi on December 5.

BioSpectrum India, in consultation with a six-member jury panel chaired by Dr Renu Swarup, Former Secretary, Department of Biotechnology, Government of India, selected Dilip Shanghvi for this prestigious award for his continuous and dedicated service towards the world-wide betterment of the health of the present and future generations.

The Union Minister of State (Independent Charge) for Science and Technology, Dr Jitendra Singh who served as Chief Guest, presented the awards in presence of Dr Renu Swarup.

Dilip Shanghvi, in his acceptance speech (in a pre-recorded message) said “I am truly honoured to receive this recognition and award today. I accept it on behalf of the entire Sun Pharmaceutical team, who have consistently gone above and beyond the call of duty. Their commitment and hard work have enabled our company to continue growing faster than the industry.”

He further said “The Indian pharmaceutical industry has, for many years, continued to excel and has increasingly become an important pillar of the global pharma landscape. Today, India is proudly regarded as the ‘pharmacy of the world’. I am happy that Sun Pharmaceutical has played a meaningful role in this journey. Looking ahead, I envision a future where Indian companies — and India as a nation — not only contribute to the global generics market, but also emerge as leaders in innovation, bringing new and transformative treatments to patients worldwide.”

Dr Azadar Khan, VP-Corporate Affairs, Sun Pharma received the award on Dilip Shanghvi's behalf.

Welcoming the august gathering including Union Minister of State (Independent Charge) for Science and Technology, Dr Jitendra Singh, Ravindra Boratkar, Publisher & Managing Editor, BioSpectrum India and Managing Trustee, MMA Spectrum Foundation said “Today, we come together to honour the pioneers, the visionaries, the risk-takers, and the path-breakers who are shaping the future of biotechnology, pharmaceuticals, medtech, diagnostics, digital health, and research. Your work not only strengthens India’s scientific capabilities but also touches millions of lives across the world. The Excellence Awards represent the highest recognition in this journey, celebrating commitment to innovation, ethical leadership, and societal impact.”

Sharing her views as the chairperson of the Jury Panel Dr Renu Swarup, former Secretary, Department of Biotechnology, said “The entire selection process was extremely robust, with the BioSpectrum team conducting extensive research to identify nominees before presenting them to the jury. The most satisfying moment for the jury is when we receive strong, high-quality nominations — and this year, the nominations were exceptionally rich in contribution. All jury members would agree that it took considerable deliberation to finalize the awardees because the level of competition was so high. This reflects both the strength of the biotechnology sector and the diligence of the evaluation process. During our discussions, the jury also emphasized the importance of recognizing young talent in the future, as nurturing this pipeline is essential for sustaining leadership in the biotechnology ecosystem.”

Dr Jitendra Singh began by congratulating BioSpectrum on completing 23 years and applauding its role in highlighting achievements across India’s biotech ecosystem. He expressed his appreciation for the BioSpectrum Awards, noting that such recognition plays an important role in celebrating the country’s scientific and technological progress.

Dr Singh shared updates on key government initiatives, including the upcoming Smart Tech India programme and the Department of Biotechnology’s increasing focus on stress biology—a field that is expanding significantly. He emphasized that the ecosystem in India is now better prepared than ever for scientific growth, reflecting a stronger foundation and more supportive policies. He also referenced the newly introduced Bio-E3 Policy, designed to boost India’s bioeconomy and strengthen the nation's standing in global biotechnology. Concluding his remarks, he commended the award winners.

Other esteemed Juries included: Dr Jitendra Kumar, Managing Director, Biotechnology Industry Research Assistance Council (BIRAC); Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance; Dr Sanghamitra Pati, Additional Director General, Indian Council of Medical Research; Dr Shirshendu Mukherjee, Managing Director, Wadhwani Innovation Network; and Prof. Vijay Chandru, Founder and Chairperson, Strand Life Sciences.

List of Jury Award Winners

• Entrepreneur of the Year 2024 - Ajit Patil & Amit Kharat, Co-Founders, DeepTek.ai
• Entrepreneur of the Year 2025 - Hitesh Goswami & Kshitij Rishi, Co-Founders, 4baseCare
• Woman Entrepreneur of the Year 2024 -Dr Latha Poonamallee, Co-Founder, In-Med Prognostics
• Woman Entrepreneur of the Year 2025 - Dr Ria Khurana, Co-Founder, RNT Health Insights
• Jury Special Award for Woman Scientist of the Year 2024 - Prof Gaiti Hasan, Distinguished Fellow, National Centre for Biological Sciences
• Jury Special Award for Woman Scientist in Clinical Research of the Year 2024 - Prof. Shinjini Bhatnagar, Professor of Eminence, Translational Health Science and Technology Institute
• Jury Special Award for Woman Scientist of the Year 2025 - Dr Radha Rangarajan, Director, CSIR-Central Drug Research Institute 
• Product of the Year 2024 - Havisure Vaccine by Indian Immunologicals
• Product of the Year 2025 - Miqnaf (Nafithromycin) by Wockhardt
• Businessperson of the Year 2024 (Medium Company) -Dr Vedam Ramprasad, CEO, MedGenome
• Businessperson of the Year 2025 (Big Company) - Dr Sharvil Patel, Managing Director, Zydus Lifesciences
• Businessperson of the Year 2025 (Medium Company) - Sriram Natarajan, CEO, Molbio Diagnostics
• Best Performing State of the Year 2025 – Telangana and Karnataka

Special Recognition Award 2025

The winners for the Special Recognition Awards have been selected after reviewing numerous nominations, to turn the spotlight onto companies we believe will lead the way in the near future, not only in India but globally. Through these awards, BioSpectrum India is playing the role of picking tomorrow's winners, nudging today's entrepreneurs to achieve greater glory and honouring yesterday's key players who laid the foundation for success.

 Winners of the Special Recognition Awards 2025-

• Top Diagnostics Leader- Roche Diagnostics India
• Excellence in Diagnostics- Vanguard Diagnostics
• Outstanding Contribution to Biotech Ecosystem- Serum Institute of India
• Excellence in BioServices- Vipragen Biosciences
• Best Vaccine Efforts of the Year- TechInvention Lifecare
• Excellence in Lab Consumables- Abdos Life Sciences
• Top Emerging Biotech Company- PharmNXT Biotech
• Top Emerging MedTech Company- Sebia Diagnostics India
• Global Expansion Excellence in MedTech- Poly Medicure
• Excellence in Cancer Diagnostics and Biomarker Innovation- OncoStem Diagnostics
• Excellence in Global Health Innovation- Foundation for Neglected Disease Research
• Top Digital Health Company- Plus91 Technologies
• Special Recognition in Cell & Gene Therapy- Miltenyi Biotec
• Leading Translational Biotech Organisation- HiMedia Laboratories
• Excellence in Industrial Microbiology- Biomerieux India
• Distinguished BioSupplier Partner- HiMedia Laboratories

On the theme “Transforming India into a life sciences powerhouse: Journey Ahead into 2047!” distinguish panellists including Dr Jitendra Kumar, Managing Director, BIRAC; Priya G Hingorani, Managing Director of Miltenyi Biotec India; Dr Vishal Warke, Director Research & Development (Microbiology), HiMedia Laboratories; and Dr Arjun Dang, CEO & Partner, Dr Dangs Lab shared their views on the topic, with the moderator Dr Manbeena Chawla, Executive Editor, BioSpectrum India & Asia.

Telecasted by CNBC, this glittering show was supported by HiMedia Laboratories, Lonza, Eppendorf, Biomerieux, Dräger, Medidata, Duoning Biotech. Dr Milind Kokje, Executive Trustee, MMA Spectrum Foundation proposed vote of thanks.